세계의 인슐린 주입 펌프 시장 보고서(2025년)
Insulin Infusion Pump Global Market Report 2025
상품코드 : 1760570
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,700,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,685,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,669,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

인슐린 주입 펌프 시장 규모는 향후 몇 년 동안 급속한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 원격 의료 서비스에 대한 접근성 확대, 만성 질환 사례의 증가, 개인 맞춤형 의약품에 대한 수요 증가, 의료비 지출 증가, 의사와 환자 모두의 인식 제고 등의 요인에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 폐쇄 루프 시스템의 발전, 인공 지능(AI) 및 기계 학습의 통합, 무선 연결 기술의 발전, 펌프 소형화의 발전, 웨어러블 기기의 통합 등이 있습니다.

인슐린 주입 펌프 시장은 당뇨병의 유병률이 계속 증가함에 따라 성장할 것으로 예상됩니다. 당뇨병은 신체가 혈당 또는 포도당 수치를 조절하는 데 어려움을 겪는 만성 질환입니다. 당뇨병 발병률이 증가하는 주요 원인은 주로 앉아있는 생활 방식과 잘못된 식습관으로, 이는 비만, 인슐린 저항성, 제2형 당뇨병 발병률 증가로 이어집니다. 인슐린 주입 펌프는 인슐린을 지속적으로 정밀하게 주입하여 혈당 수치를 안정적으로 유지함으로써 당뇨병을 관리하는 데 도움이 됩니다. 이 펌프는 잦은 주사 횟수를 줄여 편의성을 높이고 혈당 조절을 개선하여 궁극적으로 당뇨병 치료를 개선합니다. 예를 들어, 2024년 6월 영국 국민보건서비스(NHS)는 2023년 영국에서 361만 5,330명이 비당뇨병성 고혈당 또는 당뇨병 예비군으로 진단되어 2022년 306만 5,825명에서 18% 증가했다고 보고했습니다.

인슐린 주입 펌프 시장의 선도 기업들은 인슐린 패치 펌프 시스템과 같은 혁신적인 제품 개발에 주력하여 편의성과 휴대성을 개선하고, 환자에게 더욱 신중하고 편안한 인슐린 투여 옵션을 제공하고 있습니다. 인슐린 패치 펌프는 피부를 통해 인슐린을 투여하는 소형 웨어러블 기기로, 기존의 튜브가 필요하지 않습니다. 2023년 11월, 네덜란드에 본사를 둔 의료 기기 회사인 ViCentra BV는 Kaleido 인슐린 패치 펌프와 Diabeloop DBLG1 알고리즘 및 Dexcom G6 연속 혈당 모니터링을 결합한 하이브리드 폐쇄 루프 시스템을 출시했습니다. 이 통합 인공 췌장은 인슐린 투여량을 실시간으로 자동 조정하여 저혈당을 크게 줄이고 제1형 당뇨병 환자의 혈당 조절 및 정상 혈당 유지 시간을 개선합니다. 이 시스템은 사용자 친화적이며, 지문 채혈 테스트 없이 최소한의 설정만으로 사용 가능하며, 데이터를 클라우드 플랫폼에 업로드하여 사용자와 의료진이 쉽게 모니터링할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

An insulin infusion pump is a small, wearable device designed for the continuous delivery of insulin to individuals with diabetes, helping maintain optimal blood glucose levels. It administers insulin through a catheter placed under the skin, offering more precise and flexible management compared to multiple daily injections.

The main types of insulin infusion pumps include continuous subcutaneous insulin infusion (CSII) pumps, insulin delivery pens, and wearable insulin pumps. Continuous Subcutaneous Insulin Infusion (CSII) pumps are medical devices that deliver a steady, continuous dose of rapid-acting insulin via a small catheter placed under the skin. Technologies involved in these pumps include remote monitoring systems, closed-loop systems, and smart insulin pumps. These devices are used in various settings such as hospitals, home care environments, and diabetes clinics.

The insulin infusion pumps market research report is one of a series of new reports from The Business Research Company that provides insulin infusion pumps market statistics, including the insulin infusion pumps industry's global market size, regional shares, competitors with the insulin infusion pumps market share, detailed insulin infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the insulin infusion pumps market. This insulin infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The insulin infusion pump market size has grown rapidly in recent years. It will grow from $6.33 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historical period can be attributed to factors such as the rising incidence and prevalence of diabetes, the increasing rate of obesity, the growing demand for integrated systems, heightened awareness and education, and improved reimbursement policies.

The insulin infusion pump market size is expected to rapid growth in the next few years. It will grow to $10.31 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to factors such as expanding access to telehealth services, a rise in chronic disease cases, increasing demand for personalized medicine, higher healthcare expenditure, and growing awareness among both physicians and patients. Key trends in the forecast period include advancements in closed-loop systems, the integration of artificial intelligence (AI) and machine learning, technological progress in wireless connectivity, advancements in pump miniaturization, and the integration of wearable devices.

The insulin infusion pump market is projected to grow as the prevalence of diabetes continues to rise. Diabetes is a chronic condition in which the body struggles to regulate blood sugar or glucose levels. The increasing rates of diabetes are primarily attributed to sedentary lifestyles and poor dietary choices, which lead to obesity, insulin resistance, and higher incidences of type 2 diabetes. Insulin infusion pumps help manage diabetes by delivering continuous, precise doses of insulin, ensuring stable blood glucose levels. They reduce the need for frequent injections, offering convenience and better control over blood sugar, ultimately improving diabetes care. For example, in June 2024, the National Health Service (NHS) reported that in 2023, 3,615,330 individuals in the UK were diagnosed with non-diabetic hyperglycemia or pre-diabetes, marking an 18% increase from 3,065,825 cases in 2022. This growing prevalence of lifestyle-related diseases is expected to drive the expansion of the medical device safety testing market.

Leading companies in the insulin infusion pump market are focusing on developing innovative products, such as insulin patch pump systems, to improve convenience, portability, and offer more discreet and comfortable insulin delivery options for patients. Insulin patch pumps are small, wearable devices that administer insulin through the skin, eliminating the need for traditional tubing. In November 2023, ViCentra BV, a Netherlands-based medical device company, launched a hybrid closed-loop system that combines its Kaleido insulin patch pump with the Diabeloop DBLG1 algorithm and Dexcom G6 continuous glucose monitoring. This integrated artificial pancreas automatically adjusts insulin dosing in real-time, significantly reducing hypoglycemia and improving glucose control and time in range for individuals with type 1 diabetes. The system is user-friendly, requires minimal setup without fingerstick tests, and uploads data to a cloud platform for easy monitoring by both users and healthcare providers.

In May 2023, Medtronic plc, an Ireland-based medical technology company, acquired EOFlow for $738 million. The acquisition is part of Medtronic's strategy to enhance its diabetes management portfolio by integrating EOFlow's cutting-edge wearable insulin delivery technology. EOFlow Co. Ltd., based in South Korea, is a medical technology company focused on developing wearable and disposable insulin patch pumps to improve diabetes management.

Major players in the insulin infusion pump market are Pfizer Inc., Roche Holding AG, Sanofi S.A., Medtronic plc, Eli Lilly and Company, Becton, Dickinson and Company, Baxter International Inc., Terumo Corporation, Smiths Group plc, Moog Inc., ICU Medical Inc., Insulet Corporation, MicroPort Scientific Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, B. Braun Melsungen AG, Beta Bionics Inc., SOOIL Development Co. Ltd., Fresenius SE & Co. KGaA, Shinmyung Mediyes Co. Ltd.

North America was the largest region in the insulin infusion pump market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in insulin infusion pump report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the insulin infusion pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The insulin infusion pump market consists of revenues earned by entities providing services such as bolus insulin delivery, customizable dosing schedules, and blood glucose monitoring integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The insulin infusion pump market also includes sales of tubed insulin pumps, rechargeable and disposable pump units, smart pump controllers, and integrated CGM-compatible devices designed to improve glycemic control in diabetes patients. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Insulin Infusion Pump Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on insulin infusion pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for insulin infusion pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The insulin infusion pump market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Insulin Infusion Pump Market Characteristics

3. Insulin Infusion Pump Market Trends And Strategies

4. Insulin Infusion Pump Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Insulin Infusion Pump Growth Analysis And Strategic Analysis Framework

6. Insulin Infusion Pump Market Segmentation

7. Insulin Infusion Pump Market Regional And Country Analysis

8. Asia-Pacific Insulin Infusion Pump Market

9. China Insulin Infusion Pump Market

10. India Insulin Infusion Pump Market

11. Japan Insulin Infusion Pump Market

12. Australia Insulin Infusion Pump Market

13. Indonesia Insulin Infusion Pump Market

14. South Korea Insulin Infusion Pump Market

15. Western Europe Insulin Infusion Pump Market

16. UK Insulin Infusion Pump Market

17. Germany Insulin Infusion Pump Market

18. France Insulin Infusion Pump Market

19. Italy Insulin Infusion Pump Market

20. Spain Insulin Infusion Pump Market

21. Eastern Europe Insulin Infusion Pump Market

22. Russia Insulin Infusion Pump Market

23. North America Insulin Infusion Pump Market

24. USA Insulin Infusion Pump Market

25. Canada Insulin Infusion Pump Market

26. South America Insulin Infusion Pump Market

27. Brazil Insulin Infusion Pump Market

28. Middle East Insulin Infusion Pump Market

29. Africa Insulin Infusion Pump Market

30. Insulin Infusion Pump Market Competitive Landscape And Company Profiles

31. Insulin Infusion Pump Market Other Major And Innovative Companies

32. Global Insulin Infusion Pump Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Insulin Infusion Pump Market

34. Recent Developments In The Insulin Infusion Pump Market

35. Insulin Infusion Pump Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기